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Cell-free DNA release during programmed cell death in ischemia reperfusion injury 
 
 Transplantation is invariably associated with acute allograft injury caused by ischemia 
reperfusion injury (IRI). This injury causes cells of the allograft to undergo various forms of 
programmed cell death including apoptosis and necroptosis. During programmed cell death, 
immunogenic molecules are released from cells, one of which is cell-free DNA (cfDNA). We 
hypothesize that cfDNA is released by microvascular endothelial cells (MVECs) during 
programmed cell death of IRI and that cfDNA acts as both a biomarker for cellular injury as well 
as a biologically active molecule capable of amplifying inflammation and organ injury. 
 
 Our results indicate that cfDNA is released by MVECs under both apoptotic and 
necroptotic conditions in vitro, as well as during IRI in an in vivo mouse model. We have also 
shown that cfDNA release is ameliorated by blocking necroptosis in vivo with the use of RIPK3-/- 
mice that are incapable of undergoing necroptosis. Lastly, we have shown that cfDNA is capable 
of activating immune cells, showing that NK cell activation markers are upregulated when 
purified NK cells are subjected to cfDNA in vitro.  
 
 Our results indicate that cfDNA is a potential biomarker of allograft injury in a renal 
transplant setting. Donor-derived cfDNA from blood or urine may give rise to novel non-
invasive tests to diagnose graft damage. cfDNA also appears to exacerbate inflammation by 
activating immune cells to produce pro-inflammatory cytokines which further escalates 
inflammation. It may be prudent to inhibit the release of cfDNA in a transplant scenario, a goal 
our lab is currently working towards.  
 
